Extracorporeal Shock Wave Lithotripsy is a non-invasive medical procedure that uses shock waves to break up kidney stones and gallstones outside the body. The shock waves are generated by passing electricity through a conductive medium which causes explosive vaporization of water and emissions of shock waves. These waves are focused on stones present inside the kidney or gallbladder through ultrasound or X-ray guidance, fragmenting them into smaller pieces which can pass out of the body in urine.

The Extracorporeal Shock Wave Lithotripsy market is estimated to be valued at US$ 443 Mn in 2023 and is expected to exhibit a CAGR of 6.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

The Global Extracorporeal Shock Wave Lithotripsy Market Size is expected to witness significant growth over the forecast period owing to rising prevalence of kidney stones and technological advancements in ESWL procedures. According to the National Kidney Foundation, approximately 1 in 11 people in the U.S. have kidney stones at some point. Additionally, dietary and lifestyle changes are making kidney stones more common. The increasing preference for non-invasive treatment options is also fueling adoption of ESWL systems, as it causes minimal trauma compared to ureteroscopy or percutaneous nephrolithotomy. Furthermore, continuous innovations such as the development of electro-hydraulic lithotripters with advanced imaging capabilities are making these procedures more effective and accurate, thereby propelling the market growth. However, availability of alternative treatments such as ureteroscopy may hamper the market growth.

SWOT Analysis

Strength: Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive procedure that uses focused shock waves to break up kidney stones and gallstones into smaller fragments. It does not require surgical incision or general anesthesia. ESWL is considered the first-line treatment for many patients with kidney stones or gallstones.

Weakness: ESWL treatment may require multiple sessions to completely break up larger stones. There is a risk of stone fragments remaining in the kidney or gallbladder that may require additional procedures. ESWL is not effective for treating all types of stones.

Opportunity: Growing geriatric population prone to develop kidney stones and gallstones presents an opportunity. Increasing preference for minimally invasive procedures over traditional surgeries boosts demand.

Threats: Advancements in alternative stone treatment technologies such as ureteroscopy may limit the use of ESWL for some patients. Stringent regulatory environment adds to compliance challenges.

Key Takeaways

The global extracorporeal shock wave lithotripsy market is expected to witness high growth, exhibiting CAGR of 6.2% over the forecast period, due to increasing prevalence of kidney stones and gallstones. As per an estimate, over 1 million Americans are diagnosed with kidney stones annually, causing severe pain.

Regional analysis: North America dominates the global market currently owing to increasing healthcare expenditure and technological advancements. Asia Pacific is anticipated to be the fastest growing market driven by growing medical tourism, rising cases of urolithiasis, and improving access to healthcare.

Key players: Key players operating in the extracorporeal shock wave lithotripsy market are Siemens AG, Dornier MedTech GmbH, Olympus America, Richard Wolf, Boston Scientific, EDAP TMS, Urologix Inc., Guangdong Haifu Medical Technology Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., Jiangsu Yuyue Medical Equipment Co., Ltd.

For More Insights, Read- https://www.trendingwebwire.com/extracorporeal-shock-wave-lithotripsy-market-analysis-growth-forecast-outlook-2023-2030/